Evidence map›Paper›PMID 21951193›Full record

ReviewJournal of neuroendocrinology2012

Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems.

C A Frye, E Bo, G Calamandrei, L Calzà, F Dessì-Fulgheri, M Fernández, L Fusani, O Kah, M Kajta, Y Le Page and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroendocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 421 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

C A FryeDepartment of Psychology, The University at Albany-SUNY, Albany, NY 12222, USA. cafrye@albany.edu
E Bo
G Calamandrei
L Calzà
F Dessì-Fulgheri
M Fernández
L Fusani
O Kah
M Kajta
Y Le Page
H B Patisaul
A Venerosi
A K Wojtowicz
G C Panzica
Neuroscience Institute · ITNorth Carolina State University · USPolish Academy of Sciences · PLUniversity at Albany, State University of New York · USUniversity of Bologna · ITUniversity of Ferrara · IT

Funding

Progestogens' non-classical effects and mechanisms for social & mood processesR01MH067698 · NIMH · UNIVERSITY OF ALASKA FAIRBANKS · PI DREW, KELLY L · 2004 to 2013
$2.4M
Progestins' non-genomic actions for socio-sexual behaviorR56MH067698 · NIMH · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI FRYE, CHERYL ANNE · 2009 to 2009
$379k
NIMH NIH HHS MH067698NIMH NIH HHS R01 MH067698PHS HHS 067698
6 · The paper itself

Abstract

Some environmental contaminants interact with hormones and may exert adverse consequences as a result of their actions as endocrine disrupting chemicals (EDCs). Exposure in people is typically a result of contamination of the food chain, inhalation of contaminated house dust or occupational exposure. EDCs include pesticides and herbicides (such as dichlorodiphenyl trichloroethane or its metabolites), methoxychlor, biocides, heat stabilisers and chemical catalysts (such as tributyltin), plastic contaminants (e.g. bisphenol A), pharmaceuticals (i.e. diethylstilbestrol; 17α-ethinylestradiol) or dietary components (such as phytoestrogens). The goal of this review is to address the sources, effects and actions of EDCs, with an emphasis on topics discussed at the International Congress on Steroids and the Nervous System. EDCs may alter reproductively-relevant or nonreproductive, sexually-dimorphic behaviours. In addition, EDCs may have significant effects on neurodevelopmental processes, influencing the morphology of sexually-dimorphic cerebral circuits. Exposure to EDCs is more dangerous if it occurs during specific 'critical periods' of life, such as intrauterine, perinatal, juvenile or puberty periods, when organisms are more sensitive to hormonal disruption, compared to other periods. However, exposure to EDCs in adulthood can also alter physiology. Several EDCs are xenoestrogens, which can alter serum lipid concentrations or metabolism enzymes that are necessary for converting cholesterol to steroid hormones. This can ultimately alter the production of oestradiol and/or other steroids. Finally, many EDCs may have actions via (or independent of) classic actions at cognate steroid receptors. EDCs may have effects through numerous other substrates, such as the aryl hydrocarbon receptor, the peroxisome proliferator-activated receptor and the retinoid X receptor, signal transduction pathways, calcium influx and/or neurotransmitter receptors. Thus, EDCs, from varied sources, may have organisational effects during development and/or activational effects in adulthood that influence sexually-dimorphic, reproductively-relevant processes or other functions, by mimicking, antagonising or altering steroidal actions.

Indexed as

AnimalsBehavior, AnimalBenzhydryl CompoundsBisphenol A CompoundsBrainEndocrine DisruptorsEnvironmental PollutantsHumansPhenolsPhytoestrogensPubertyReproductionBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsEnvironmental PollutantsPhenolsPhytoestrogens

Identifiers

PMID21951193
PMCPMC3245362
OpenAlexW2158159969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.